Article

Glaucoma 360 founders discuss innovation at 2019 meeting

Conferences|GLAUCOMA 360

Drs. Graves and Iwach, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.

Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
Related Content
Altris AI launches advanced glaucoma Optic Disc Analysis module
March 9th 2025

Altris AI launches advanced glaucoma Optic Disc Analysis module

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

New analysis on Mont Blanc Phase 3 trial for NCX 470 for patients with OAG released by Nicox
March 7th 2025

New analysis on Mont Blanc Phase 3 trial for NCX 470 for patients with OAG released by Nicox

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Ophthalmology balances the promises and challenges of AI
March 4th 2025

Ophthalmology balances the promises and challenges of AI

Perceive Pharma closes funding for $15M Series A therapy
February 26th 2025

Perceive Pharma closes funding for $15M Series A therapy

© 2025 MJH Life Sciences

All rights reserved.